Form 8-K - Current report:
SEC Accession No. 0001558370-23-005439
Filing Date
2023-04-04
Accepted
2023-04-04 16:05:21
Documents
13
Period of Report
2023-03-31
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gbio-20230331x8k.htm   iXBRL 8-K 44423
2 EX-3.1 gbio-20230331xex3d1.htm EX-3.1 141487
  Complete submission text file 0001558370-23-005439.txt   329044

Data Files

Seq Description Document Type Size
3 EX-101.SCH gbio-20230331.xsd EX-101.SCH 3108
4 EX-101.LAB gbio-20230331_lab.xml EX-101.LAB 13005
5 EX-101.PRE gbio-20230331_pre.xml EX-101.PRE 11204
7 EXTRACTED XBRL INSTANCE DOCUMENT gbio-20230331x8k_htm.xml XML 4850
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 857-529-5908
Generation Bio Co. (Filer) CIK: 0001733294 (see all company filings)

EIN.: 814301281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39319 | Film No.: 23797266
SIC: 2834 Pharmaceutical Preparations